Pharmaceutical services company AmerisourceBergen Corp. (ABC) announced Wednesday that it will reaffirm its prior forecast for the full-year 2012 at its investor day meeting in New York City later in the day. The company expects earnings for fiscal 2012 to grow 8 percent to 12 percent from last year, on an assumed annual revenue growth of between flat and modest.
The Valley Forge, Pennsylvania-based company will reaffirm its earnings forecast for fiscal 2012 in a range of $2.74 to $2.84 per share, representing an 8 percent to 12 percent increase from last year's earnings of $2.54 per share.
On average, 13 analysts polled by Thomson Reuters currently expect the company to report earnings of between $2.78 and $2.85 per share for the full-year 2012, with a consensus of $2.81 per share. Analysts' estimates typically exclude special items.
The company also anticipates full-year 2012 revenue to grow between flat and modestly from the annual revenues of $80.22 billion reported for fiscal 2011.
Sixteen Wall Street analysts currently have a consensus revenue estimate of $80.84 billion for the full-year 2012, with estimates ranging between $79.46 billion and $82.63 billion.
The company's key assumptions for fiscal 2012 earnings forecast continue to be revenue growth of flat to modestly, with operating margin growth expected in the high single-digit to low double-digit basis points range.
The company noted that free cash flow is still assumed to be in the range of $700 million to $800 million, including capital expenditures in the $150 million range. The company also plans to repurchase about $400 million of its common shares in the fiscal year 2012.
In early November, AmerisourceBergen reported a 4.3 percent year-over-year increase in profit for the fourth quarter, driven by strong generic drug sales and solid performance under fee-for-service contracts with manufacturers. Net income grew to $147.32 million or $0.54 per share from $141.23 million or $0.50 per share in the year-ago quarter. Quarterly revenues rose 3.5 percent to $20.41 billion from $19.72 billion last year, reflecting a 6 percent increase in AmerisourceBergen Drug Corp. revenue.
Later in November, the company boosted its quarterly dividend rate by 13 percent to $0.13 per share, paid on December 5 to stockholders of record at the close of business on November 21, 2011.
In Wednesday's regular trading session, ABC is currently trading at $35.76, down $0.10 or 0.28 percent on a volume of 76,854 shares.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.